Reports: Analysis of public health data (Latvia): Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::Slimību Profilakses un Kontroles Centrs (SPKC)]]. | '''Sponsor, manager or home institution:''' [[dataOwner::Slimību Profilakses un Kontroles Centrs (SPKC)]]. | ||
'''Type of information:''' Most common [[availableVariable::diagnosis|malignant | '''Type of information:''' Most common [[availableVariable::diagnosis|malignant tumours]]; [[availableVariable::potential years of life lost]] due malignant tumours; [[availableVariable::number of deaths|Mortality]] from malignant tumours; [[availableVariable::causes of death]], [[availableVariable::cancer incidence]] and [[availableVariable::cancer prevalence]]; Five-year [[availableVariable::cancer survival]] rate for patients diagnosed by type of malignant tumour; Distribution of patients by [[availableVariable::tumour staging|stage]] at the time of diagnosis; Rate population coverage of [[availableVariable::screening]]s programs. | ||
'''Data level:''' [[dataLevel::national level]]. | '''Data level:''' [[dataLevel::national level]]. | ||
Revision as of 15:32, 27 August 2024
Go back to Latvia page
Primary purpose: To implement public health policies related to epidemiological safety, disease prevention, health care quality, and health promotion, while also coordinating these efforts.
Sponsor, manager or home institution: Slimību Profilakses un Kontroles Centrs (SPKC).
Type of information: Most common malignant tumours; potential years of life lost due malignant tumours; Mortality from malignant tumours; causes of death, cancer incidence and cancer prevalence; Five-year cancer survival rate for patients diagnosed by type of malignant tumour; Distribution of patients by stage at the time of diagnosis; Rate population coverage of screenings programs.
Data level: national level.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more
Access to information: Click here to access.